cancer
Research Roundup
Debbie Rigby rounds up the latest in research news Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease A systematic review and meta-analysis has shown non–vitamin K oral …
New listings
Health Minister Greg Hunt has announced four medicine listings through the PBS from 1 August Mr Hunt says that the Morrison Government will invest $56 million in subsiding the medicines, …
Trekking for teal
Nine pharmacists, support staff and a CEO are heading to Kokoda to raise money for ovarian cancer patients Newly appointed TerryWhite Chemmart CEO Duncan Phillips is among the group which …
An Australian first
Pembrolizumab (Keytruda) is the first medicine to have additional indications registered on the ARTG via the TGA’s provisional approval pathway “Pembrolizumab’s indications now include the treatment of patients with metastatic …
Pharmacists ‘instrumental’ in uncovering under-dosing error
There is a “clear need” for pharmacists to be involved in the chemotherapy protocol alteration and promulgation system in South Australia, a deputy coroner says The inquest into the deaths …
‘Stop asking the wrong question about lung cancer’
A new campaign by Lung Foundation Australia is asking for a fair go for all lung cancer patients, highlighting the stigma they can face More than a third (35%) of …
Body fat and breast cancer
Obesity is associated with an increased risk of breast cancer – but women with a normal BMI could still be at risk Women with excess body fat, even if they …
Case study: pembrolizumab
Researchers have highlighted a case where this newly listed medication led to drug‐induced autoimmune diabetes mellitus and colitis Pharmacist Nikhil Singh from the Royal Melbourne Hospital has shared a case …
Clinical tips: skin cancer
Louis Roller takes an in-depth look at skin cancer Approximately two in three Australians will be diagnosed with skin cancer by the time they are 70, with more than 750,000 …
Cancer patients using alternative meds unaware of risks
Pharmacist medication reviews are “crucial” to preventing drug-drug interactions including CAMs in oncology, say international researchers Two studies presented at the European Society for Medical Oncology (ESMO) 2018 Congress in …
Non-CVD statin evidence lacking
A review of the benefits of statins has found a lack of convincing evidence for the drugs’ use in helping prevent conditions such as cancer and Alzheimer’s disease While some …
The week in review
It’s been a mixed bag of news in the pharmacy sector this week, as discussion of the aged care sector continues, hospital pharmacy was under the spotlight and a focus …